Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Mastronuzzi

Showing results (231-240 of 261) with videos related to

Pageof 27
Sort By:
Cancer Medicine|September 2, 2025
Eye Salvage and Vision Preservation in High-Risk Intraocular Retinoblastoma Patients: Long-Term Results From the Prospective Phase II AIEOP RTB 012 StudyIda Russo, Valentina Di Ruscio, Maria Antonietta De Ioris, et al.
Neuropathology and Applied Neurobiology|July 13, 2026
Utility of Optical Genome Mapping in the Characterisation of the Global Genomic Architecture of Paediatric Central Nervous System Tumours: A Pilot StudyViola Alesi, Silvia Genovese, Serena Russo, et al.
Molecular Therapy. Nucleic Acids|June 3, 2026
Exploration of miR-326 delivery via biocompatible polymeric nanoparticles in medulloblastoma: A preliminary studyElena Splendiani, Gabriele Maiorano, Zaira Spinello, et al.
Pediatric Blood & Cancer|May 19, 2025
Food Safety Practices and Foodborne Illness in Italian Pediatric Oncology and Hematology Centers: A Survey on Behalf of the Infectious Disease Working Group of AIEOPDavide Leardini, Gianluca Bossù, Francesco Venturelli, et al.
Acta Neuropathologica|November 30, 2019
Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic markerAndrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Neuro-Oncology|October 4, 2021
Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocolMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Neuro-Oncology|December 29, 2021
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutantEmmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Nature Medicine|September 9, 2025
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Acta Neuropathologica|July 24, 2021
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signallingFrancesca Nazio, Agnese Po, Luana Abballe, et al.
Cancer Letters|February 29, 2024
Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective studyEvelina Miele, Elena Anghileri, Chiara Calatozzolo, et al.
Pageof 27

Showing results (231-240 of 261) with videos related to

Sort By:
Pageof 27
Cancer Medicine|September 2, 2025
Eye Salvage and Vision Preservation in High-Risk Intraocular Retinoblastoma Patients: Long-Term Results From the Prospective Phase II AIEOP RTB 012 StudyIda Russo, Valentina Di Ruscio, Maria Antonietta De Ioris, et al.
Neuropathology and Applied Neurobiology|July 13, 2026
Utility of Optical Genome Mapping in the Characterisation of the Global Genomic Architecture of Paediatric Central Nervous System Tumours: A Pilot StudyViola Alesi, Silvia Genovese, Serena Russo, et al.
Molecular Therapy. Nucleic Acids|June 3, 2026
Exploration of miR-326 delivery via biocompatible polymeric nanoparticles in medulloblastoma: A preliminary studyElena Splendiani, Gabriele Maiorano, Zaira Spinello, et al.
Pediatric Blood & Cancer|May 19, 2025
Food Safety Practices and Foodborne Illness in Italian Pediatric Oncology and Hematology Centers: A Survey on Behalf of the Infectious Disease Working Group of AIEOPDavide Leardini, Gianluca Bossù, Francesco Venturelli, et al.
Acta Neuropathologica|November 30, 2019
Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic markerAndrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Neuro-Oncology|October 4, 2021
Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocolMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Neuro-Oncology|December 29, 2021
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutantEmmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Nature Medicine|September 9, 2025
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Acta Neuropathologica|July 24, 2021
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signallingFrancesca Nazio, Agnese Po, Luana Abballe, et al.
Cancer Letters|February 29, 2024
Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective studyEvelina Miele, Elena Anghileri, Chiara Calatozzolo, et al.
Pageof 27